Chain Bridge I (CBRG)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential
NEW YORK and SANTA BARBARA, Calif., July 30, 2024 – Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its new investor deck.
Chain Bridge I Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Highline Wealth Partners LLC Highline Wealth Partners LLC | 1,000 | $5,820 | $3,330 | -$2,490 | -42.78% |
Chain Bridge I (CBRG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Chain Bridge I ever had a stock split?
Chain Bridge I Profile
| Trading Companies & Distributors Industry | Industrials Sector | Andrew Cohen CEO | NASDAQ (CM) Exchange | 88340W483 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Chain Bridge I is a company founded in 2021 with its headquarters located in Dover, Delaware. As a business with no significant ongoing operations, Chain Bridge I’s primary focus is on identifying and executing a business combination, such as a merger, share exchange, asset acquisition, share purchase, reorganization, or a similar event with one or more companies. The sectors targeted for these activities span a wide range from technology, software, and biotechnology to digital assets, as well as more traditional industries like industrials, business services, and healthcare services. This approach indicates Chain Bridge I’s flexible and opportunistic strategy towards creating value through acquisitions and mergers.
Products and Services
Given that Chain Bridge I does not have significant operations and is primarily focused on facilitating a merger, share exchange, asset acquisition, share purchase, reorganization, or a similar business combination, the following are its intended products and services categories:
- Mergers and Acquisitions: Chain Bridge I plans to engage in identifying and executing mergers or acquisitions, focusing on companies within technology, software, biotechnology, digital assets, industrials, business services, and healthcare services sectors. Their expertise lies in scoping out potential companies for these significant business moves and structuring the deals to benefit stakeholders and drive growth.
- Share Exchange and Asset Acquisition: Another service avenue for Chain Bridge I involves conducting share exchanges or direct asset acquisitions. This would involve the transfer of ownership from one business to another in exchange for shares of the acquiring company, or through purchasing specific assets directly, allowing for strategic expansion or diversification.
- Business Reorganization and Similar Activities: Chain Bridge I also positions itself to assist in the reorganization of companies or engaging in similar business restructuring activities. This can offer companies the chance for renewal, potentially making them more efficient, competitive, and profitable, especially those within their targeted sectors.
